Literature DB >> 17632663

Risperidone-induced neuroleptic malignant syndrome in neurodegenerative disease: a case report.

Daniel Johnson1, Aby Z Philip, Dennis J Joseph, Roy Varghese.   

Abstract

Entities:  

Year:  2007        PMID： 17632663      PMCID： PMC1911173          DOI： 10.4088/pcc.v09n0311f

Source DB:  PubMed          Journal:  Prim Care Companion J Clin Psychiatry        ISSN： 1523-5998


× No keyword cloud information.
  11 in total

Review 1.  Neuroleptic malignant syndrome.

Authors:  J L Levenson
Journal:  Am J Psychiatry       Date:  1985-10       Impact factor: 18.112

2.  Neuroleptic malignant syndrome: a study of CSF monoamine metabolism.

Authors:  K Nisijima; T Ishiguro
Journal:  Biol Psychiatry       Date:  1990-02-01       Impact factor: 13.382

3.  Neuroleptic malignant syndrome in parkinsonian patients: risk factors.

Authors:  S Kuno; E Mizuta; S Yamasaki
Journal:  Eur Neurol       Date:  1997       Impact factor: 1.710

4.  Risperidone, neuroleptic malignant syndrome and probable dementia with Lewy bodies.

Authors:  G Sechi; V Agnetti; R Masuri; G A Deiana; M Pugliatti; K S Paulus; G Rosati
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2000-08       Impact factor: 5.067

5.  Neuroleptic malignant syndrome in Kufs' disease.

Authors:  A Reif; M F Schneider; A Hoyer; C Schneider-Gold; A J Fallgatter; W Roggendorf; B Pfuhlmann
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-03       Impact factor: 10.154

Review 6.  Mortality from neuroleptic malignant syndrome.

Authors:  A Shalev; H Hermesh; H Munitz
Journal:  J Clin Psychiatry       Date:  1989-01       Impact factor: 4.384

7.  Neuroleptic malignant syndrome and atypical antipsychotic drugs.

Authors:  Jambur Ananth; Sharat Parameswaran; Sarath Gunatilake; Karl Burgoyne; Taghrid Sidhom
Journal:  J Clin Psychiatry       Date:  2004-04       Impact factor: 4.384

Review 8.  Neuroleptic malignant syndrome.

Authors:  S N Caroff; S C Mann
Journal:  Med Clin North Am       Date:  1993-01       Impact factor: 5.456

Review 9.  Novel antipsychotics and the neuroleptic malignant syndrome: a review and critique.

Authors:  S Hasan; P Buckley
Journal:  Am J Psychiatry       Date:  1998-08       Impact factor: 18.112

10.  Frequency and presentation of neuroleptic malignant syndrome in a large psychiatric hospital.

Authors:  H G Pope; P E Keck; S L McElroy
Journal:  Am J Psychiatry       Date:  1986-10       Impact factor: 18.112
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.